How severe is CVE-2023-29863?

CVE-2023-29863 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-29863 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (59th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-29863?

CVE-2023-29863 affects Medisys Weblab. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-29863?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2023-29863 published?

CVE-2023-29863 was published on 2023-05-11 and last updated on 2026-07-05.

CVE-2023-29863

CVE-2023-29863 is a critical-severity vulnerability in Medisys Weblab with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Severity: Critical (CVSS 3.x base score 9.8)
EPSS exploit prediction: 1% (59th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-89
Affected product: Medisys Weblab
Published: 2023-05-11
Last modified: 2026-07-05

Description

Medical Systems Co. Medisys Weblab Products v19.4.03 was discovered to contain a SQL injection vulnerability via the tem:statement parameter in the WSDL files.

Frequently asked questions

What is CVE-2023-29863?: Medical Systems Co. Medisys Weblab Products v19.4.03 was discovered to contain a SQL injection vulnerability via the tem:statement parameter in the WSDL files.
How severe is CVE-2023-29863?: CVE-2023-29863 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-29863 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (59th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-29863?: CVE-2023-29863 affects Medisys Weblab. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-29863?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2023-29863 published?: CVE-2023-29863 was published on 2023-05-11 and last updated on 2026-07-05.

References

Affected products (1)

cpe:2.3:a:medisys:weblab:19.4.03:*:*:*:*:*:*:*

Other CWE-89 (SQL Injection) vulnerabilities

CVE-2026-54350 — Critical (CVSS 10.0): Budibase is an open-source low-code platform. Prior to 3.39.12, an unauthenticated visitor of any published Budibase…
CVE-2026-8054 — Critical (CVSS 10.0): Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in the Publish Audit API endpoints…
CVE-2026-42287 — Critical (CVSS 10.0): Emlog is an open source website building system. Prior to version 2.6.11, direct SQL injection in article creation and…
CVE-2026-3325 — Critical (CVSS 10.0): SQL injection (SQLi) in MegaCMS v12.0.0, specifically in the “id_territorio” parameter of the…
CVE-2025-10878 — Critical (CVSS 10.0): A SQL injection vulnerability exists in the login functionality of Fikir Odalari AdminPando 1.0.1 before 2026-01-26.…
CVE-2025-57792 — Critical (CVSS 10.0): Explorance Blue versions prior to 8.14.9 contain a SQL injection vulnerability caused by insufficient validation of…

Browse all CWE-89 (SQL Injection) vulnerabilities →